Aura Biosciences, Inc. (AURA) vs MiMedx Group, Inc (MDXG)

Aura Biosciences, Inc. and MiMedx Group, Inc are both Biotechnology companies. Aura Biosciences, Inc. and MiMedx Group, Inc are of similar size ($682.2M and $657.5M). Aura Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; MiMedx Group, Inc trades at 111×. MiMedx Group, Inc has the higher net margin (1.76% vs 0.00%) and the higher return on invested capital (5.62% vs 0.00%). Across the 14 metrics below, MiMedx Group, Inc leads on 11 and Aura Biosciences, Inc. on 3.

Valuation

Metric AURA MDXG Biotechnology median
P/E n/m 110.75 8.50
P/S n/m 1.84 9.71
P/B 1.84 3.03 2.13
Price to free cash flow n/m 14.74 20.82
EV/EBITDA n/m 26.27 0.64
EV/Sales n/m 1.51 9.21
Earnings yield (28.69%) 0.90% (33.15%)
Free cash flow yield (17.86%) 6.79% (25.50%)

Profitability

Metric AURA MDXG Biotechnology median
Gross margin 0.00% 78.85% 65.16%
Operating margin 0.00% 2.46% 0.00%
Net margin 0.00% 1.76% 0.00%
Free cash flow margin 0.00% 12.51% 0.00%
Return on equity (53.49%) 2.88% (56.36%)
Return on assets (47.42%) 2.18% (48.04%)
Return on invested capital 0.00% 5.62% 0.00%

Growth

Metric AURA MDXG Biotechnology median
Revenue growth (TTM) — (2.36%) 6.02%
EPS growth (last fiscal year) (0.57%) 14.29% 30.26%
Revenue growth, 5-year CAGR — 11.02% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AURA MDXG Biotechnology median
Debt to equity 0.00 0.08 0.00
Current ratio 16.82 5.33 4.72
Net debt to EBITDA 1.29 (1.88) 0.96

Dividend

Metric AURA MDXG Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AURA MDXG Biotechnology median
Market cap 657.49m 682.15m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack